We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.41B
AUM Growth
+$62.9M
Cap. Flow
-$51.7M
Cap. Flow %
-1.51%
Top 10 Hldgs %
24.31%
Holding
517
New
48
Increased
183
Reduced
127
Closed
66

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$72.9M
2
CHRW icon
C.H. Robinson
CHRW
+$68M
3
CNC icon
Centene
CNC
+$47.2M
4
VC icon
Visteon
VC
+$40.3M
5
FDS icon
Factset
FDS
+$37.9M

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Consumer Discretionary 16.74%
3 Healthcare 15.76%
4 Communication Services 11.95%
5 Industrials 11.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
226
DELISTED
Applied Genetic Technologies Corporation
AGTC
$252K 0.01%
25,720
+520
+2% +$7.01K
PIPR icon
227
Piper Sandler
PIPR
$5.29B
$248K 0.01%
+20,560
New +$224K
NUVA
228
DELISTED
NuVasive, Inc.
NUVA
$240K 0.01%
3,597
+1,149
+47% +$73.2K
RTK
229
DELISTED
Rentech, Inc.
RTK
$238K 0.01%
+81,560
New +$248K
BSET icon
230
Bassett Furniture
BSET
$169M
$236K 0.01%
10,170
+200
+2% +$5.05K
OMAB icon
231
Grupo Aeroportuario Centro Norte
OMAB
$5.24B
$235K 0.01%
4,985
SAIC icon
232
Saic
SAIC
$5.3B
$233K 0.01%
3,365
+1,139
+51% +$71.9K
LSAK icon
233
Lesaka Technologies
LSAK
$402M
$232K 0.01%
27,130
+540
+2% +$5.34K
SHI
234
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$232K 0.01%
4,543
EDU icon
235
New Oriental
EDU
$9.24B
$229K 0.01%
4,950
AMPH icon
236
Amphastar Pharmaceuticals
AMPH
$896M
$227K 0.01%
11,990
+230
+2% +$4.17K
RELX icon
237
RELX
RELX
$62.1B
$224K 0.01%
11,672
OTEX icon
238
Open Text
OTEX
$5.99B
$223K 0.01%
6,870
BMA icon
239
Banco Macro
BMA
$5.38B
$221K 0.01%
2,829
KYNB
240
Kyntra Bio
KYNB
$28.2M
$221K 0.01%
427
PTLA
241
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$220K 0.01%
9,670
ARGO
242
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$219K 0.01%
4,471
ACHN
243
DELISTED
Achillion Pharmaceuticals
ACHN
$218K 0.01%
26,890
VIPS icon
244
Vipshop
VIPS
$7.4B
$214K 0.01%
+14,581
New +$205K
ABB
245
DELISTED
ABB Ltd
ABB
$212K 0.01%
9,396
CIGI icon
246
Colliers International
CIGI
$5.11B
$204K 0.01%
4,840
TX icon
247
Ternium
TX
$10.8B
$204K 0.01%
10,405
DCM
248
DELISTED
NTT DOCOMO, Inc.
DCM
$203K 0.01%
7,980
GSK icon
249
GSK
GSK
$104B
$200K 0.01%
3,717
CM icon
250
Canadian Imperial Bank of Commerce
CM
$109B
$199K 0.01%
+5,140
New +$198K

Similar funds

Smith Group Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, Smith Group Asset Management held 517 positions worth $3.41B, up 1.9% from $3.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Smith Group Asset Management's Q3 2016 filing shows 48 new, 183 increased, 127 reduced and 66 closed positions. Its largest new stake was Nordstrom: 1,213,747 shares worth $63M. The largest sale was Bristol-Myers Squibb, an estimated $72.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Smith Group Asset Management's largest Q3 2016 buy was Nordstrom: 1,213,747 shares worth $63M.
  • Smith Group Asset Management added most to Alphabet (Google) Class A in Q3 2016, an estimated $48.4M increase.
  • Smith Group Asset Management's biggest Q3 2016 reduction was Centene, cutting an estimated $47.2M.
  • Smith Group Asset Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $72.9M.
  • Smith Group Asset Management's ten largest holdings make up 24% of its $3.41B portfolio in Q3 2016.
  • Smith Group Asset Management opened 48 new positions and closed 66 in Q3 2016.
  • Smith Group Asset Management's portfolio value rose 1.9% quarter-over-quarter to $3.41B.

Based on Smith Group Asset Management's 13F filing for Q3 2016, filed 2 Nov 2016.